Table 4.
Opportunistic infections and HIV-related conditions in a series of 135 patients with HIV/AIDS and in-hospital outcomes
| Diagnosis | Frequency n*(%) | CD4+ count median (IQR) | In-hospital deaths, n†(%) |
| Tuberculosis – any organ | 96(71.1) | 46 (12–121) | 16(16.7) |
| PTB | 11(8.1) | 46 (5–218) | 3(27.3) |
| Pleural | 4(3) | 52 (5–276) | -- |
| LNTB | 1(0.7) | 37‡ | -- |
| TBM | 8(5.9) | 58 (5–165) | 1(12.5) |
| DTB | 61(45.2) | 47 (15–127) | 11(18) |
| MTB | 11(8.1) | 27 (5–57) | 1(9.1) |
| Candidiasis | 53(39.3) | 54 (12–77) | 9(17) |
| PCP | 10(7.4) | 38 (8–69) | 4(40) |
| Herpes Zoster | 8(5.9) | 91 (59–151) | 1(12.5) |
| Cryptococcal meningitis | 5(3.7) | 135 (14–320) | 2(40) |
| Toxoplasmosis | 5(3.7) | 72 (21–132) | 1(20) |
| Cryptosporidiosis | 3(2.2) | 61 (5–116) | -- |
| CMV retinitis | 3(2.2) | 127 (37–150) | 1(33.3) |
| Giardiasis | 2(1.5) | 59 (1–116) | -- |
| Visceral leishmaniasis | 2(1.5) | 41 (5–77) | -- |
| Lymphoma | 2(1.5) | 145 (29–261) | 1(50) |
| Disseminated histoplasmosis | 1(0.7) | 51‡ | -- |
| CMV oesophagitis | 1(0.7) | 8‡ | -- |
| PMLE | 1(0.7) | 62‡ | -- |
* Not mutually exclusive; † Total will exceed the mortality of the study group; ‡ Single value; – No deaths; IQR – interquartile range; PTB – pulmonary tuberculosis; Pleural – tuberculosis pleural effusion; LNTB – lymph node tuberculosis; TBM – tuberculosis meningitis; DTB – disseminated tuberculosis; MTB – miliary tuberculosis; PCP – Pneumocystis jiroveci pneumonia; CMV – Cytomegalovirus; PMLE – progressive multifocal leucoencephalopathy.